What is the appropriate treatment for streptococcal pharyngitis in a healthy 17‑year‑old?

Treatment for Strep Throat in a 17-Year-Old

Amoxicillin 1000 mg once daily for 10 days is the recommended first-line treatment for a healthy 17-year-old with confirmed Group A streptococcal pharyngitis. 1

First-Line Antibiotic Therapy

• Amoxicillin or penicillin remains the definitive first-line choice because of proven efficacy, narrow spectrum, safety profile, low cost, and the complete absence of documented penicillin resistance in Group A Streptococcus. 2, 1, 3

• Once-daily amoxicillin 1000 mg for 10 days is the preferred regimen in adolescents and adults, offering superior adherence compared to multiple daily doses while maintaining equivalent efficacy to penicillin V. 1, 3

• Alternative dosing: Amoxicillin 500 mg twice daily for 10 days is equally effective if once-daily dosing is not feasible. 1, 3

• Penicillin V at standard adult dosing (typically 500 mg twice or three times daily) for 10 days is an acceptable alternative. 2, 3

• The full 10-day course is mandatory to ensure maximal pharyngeal eradication of Group A Streptococcus and to prevent acute rheumatic fever, even though symptoms typically resolve within 24–48 hours of starting antibiotics. 2, 1, 3

Management of Penicillin Allergy

Non-Anaphylactic Allergy (e.g., rash or hives)

• First-generation cephalosporins are the preferred alternative: cephalexin 500 mg twice daily for 10 days. 2, 1, 3

• Cross-reactivity risk with cephalosporins is minimal in non-anaphylactic penicillin allergy, and guidelines explicitly endorse their use in this scenario. 1, 3

Anaphylactic Allergy (airway compromise, hypotension, severe systemic reaction)

• Avoid all β-lactams (penicillins and cephalosporins) due to up to 10% cross-reactivity risk. 3

• Clindamycin 300 mg three times daily for 10 days is an excellent alternative with only ~1% Group A Streptococcus resistance. 1, 3

• Azithromycin 500 mg once daily for 5 days is acceptable but carries significant resistance concerns—macrolide resistance in Group A Streptococcus ranges from 5–8% in most U.S. regions and is higher in some areas. 1, 3, 4

• Clarithromycin 250 mg twice daily for 10 days is another macrolide option, subject to the same resistance limitations as azithromycin. 2, 1, 3

Symptomatic Management

• Acetaminophen or NSAIDs (e.g., ibuprofen) are recommended for moderate-to-severe throat pain or fever, providing significant symptomatic relief. 1, 3

• Systemic corticosteroids are not recommended for routine use; the modest reduction in pain duration (~5 hours) does not outweigh potential adverse effects. 1, 3

• Aspirin should be avoided in adolescents because of the risk of Reye syndrome. 1, 3

Expected Clinical Course

• Symptomatic improvement typically occurs within 24–48 hours after initiating antibiotics; lack of improvement should prompt reassessment for treatment failure or alternative diagnoses. 2, 3, 4

• Antibiotic treatment prevents acute rheumatic fever, suppurative complications (peritonsillar abscess, cervical lymphadenitis), and reduces transmission of the organism. 3

Follow-Up and Post-Treatment Testing

• Routine post-treatment throat cultures or rapid antigen tests are unnecessary after completing a full antibiotic course. 2, 1, 3

• Asymptomatic household contacts do not require testing or empiric antibiotic prophylaxis, as prophylaxis has not been shown to reduce the incidence of subsequent Group A streptococcal pharyngitis and carries risks of adverse effects and antibiotic resistance. 2, 3

Common Pitfalls to Avoid

• Do not shorten the antibiotic course below 10 days for penicillin, amoxicillin, cephalosporins, clindamycin, or clarithromycin; maximal pharyngeal eradication and rheumatic fever prevention require the full duration. 2, 1, 3

• Do not avoid first-generation cephalosporins in patients with non-anaphylactic penicillin allergies; cross-reactivity risk is minimal and guidelines explicitly endorse their use. 1, 3

• Do not prescribe tetracyclines, sulfonamides, or trimethoprim-sulfamethoxazole, as they do not eradicate Group A Streptococcus. 3

• Be aware of regional macrolide resistance patterns when prescribing azithromycin or clarithromycin, as elevated resistance rates can markedly reduce treatment success. 1, 3, 4